ResearcherDartmouth CollegeNo recent work listed
Meir Preis
Matched on ORCID iD 0000-0002-2454-0584; OpenAlex author ID A5003642570. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2011: 2 papers · 2012: 1 paper
Papers 3
- Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma. Co-author DOI 10.1093/annonc/mds109↗
- MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-11-0695↗
- Signaling pathways in pancreatic cancer. Co-author DOI 10.1615/critreveukargeneexpr.v21.i2.20↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Murray Korc · 3 shared papers, 2011–2012 · strength 0.10
- Paper Signaling pathways in pancreatic cancer. DOI 10.1615/critreveukargeneexpr.v21.i2.20↗
- Paper MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinom… DOI 10.1158/1078-0432.ccr-11-0695↗
- Paper Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreati… DOI 10.1093/annonc/mds109↗
- Stuart R. Gordon · 2 shared papers, 2011–2012 · strength 0.05
- Paper MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinom… DOI 10.1158/1078-0432.ccr-11-0695↗
- Paper Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreati… DOI 10.1093/annonc/mds109↗
- Timothy B. Gardner · 2 shared papers, 2011–2012 · strength 0.05
- Paper MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinom… DOI 10.1158/1078-0432.ccr-11-0695↗
- Paper Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreati… DOI 10.1093/annonc/mds109↗
- J. Marc Pipas · 2 shared papers, 2011–2012 · strength 0.05
- Paper MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinom… DOI 10.1158/1078-0432.ccr-11-0695↗
- Paper Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreati… DOI 10.1093/annonc/mds109↗
- Daniel S. Longnecker · 1 shared paper, 2011 · strength 0.03
- Lorenzo F. Sempere · 1 shared paper, 2011 · strength 0.03
- Gregory J. Tsongalis · 1 shared paper, 2012 · strength 0.02
- Richard J. Barth · 1 shared paper, 2012 · strength 0.02
- Bassem I. Zaki · 1 shared paper, 2012 · strength 0.02
- Arief Antonius Suriawinata · 1 shared paper, 2012 · strength 0.02
- Kerrington D. Smith · 1 shared paper, 2012 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.